Cozart Eia Amphetamines Oral Fluid Microplate Kit
Enzyme Immunoassay, Amphetamine. 510(k) K033743, from Cozart Bioscience , Ltd. (Abingdon,Oxfordshire, GB). Product code DKZ, class 2.
As of Nov 22, 2026, K033743 is an FDA 510(k) held by Cozart Bioscience , Ltd., substantially equivalent on Jun 3, 2004 after 188 days, with no recalls tied to it in FDA's recall database.
- Review time: 188 days
- Recalls: 0
- Cited as a predicate by: 1 device
The Cozart® EIA Amphetamines Oral Fluid Microplate Kit is intended for use in clinical and forensic laboratories when used in conjunction with the Cozart® RapiScan Oral Fluid collection system. Using this collection system it provides qualitative screening results for amphetamines in human oral fluid at a cutoff concentration of 15ng/ml.
- Stc Amphetamine-Specific Intercept Micro-Plate Eia, Model 1103IK992918 · OraSure Technologies, Inc. · Apr 3, 2000
- Psychemedics Microplate Eia for AmphetamineK130811 · Psychemedics Corp. · May 2, 2013
- DRI Ecstasy Plus AssayK240670 · Microgenics Corporation · Oct 30, 2024
- AllTest Multi-Drug Rapid Test Cup; AllTest Multi-Drug Rapid Test Panel; AllTest Multi-Drug Rapid Test Cup Rx; AllTest…K233019 · Hangzhou AllTest Biotech Co., Ltd. · Dec 13, 2023
- Xenta Drug Screen Cup, Xenta Drug Screen DipcardK231137 · Xenta Biomedical Science Co., Ltd. · May 19, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 28, 2003
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3100
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files